Precision, Performance & Packaging

Sterile glass vial breakage remains one of the most persistent challenges in pharmaceutical manufacturing. Every broken vial means wasted product, downtime, and higher costs, while also raising patient safety concerns. Breakage can stem from mechanical impact, thermal stress, or inherent material defects. The good news: with the right combination of equipment upgrades, material selection, handling […]

For injectable products, assuring the integrity of the container closure system (CCS) and container closure integrity is fundamental to safeguarding product quality and patient safety over the entire shelf life. Developing an inherently robust CCS is an iterative process—guided by an understanding of product stability, manufacturing methods, and anticipated distribution and storage conditions. Product protection […]

It’s usually the small changes that lead to big results and pharma giant Sanofi proved this with its pharma production line optimization project. The company’s use of SmartSkin technology for this project at their Waterford plant in Ireland resulted in a massive reduction in downtime and an improvement in yield. Here’s what Sanofi did. Production […]

Data analytics in the pharmaceutical industry is evolving from being a compliance and reporting tool to playing a strategic role in helping take informed decisions. When used correctly, data analysis can play a big role in taking operational decisions, preventing time overruns, reducing quality related issues and unlocking Overall Equipment Efficiency (OEE) in the pharma […]

In pharmaceutical fill-and-finish operations, maintaining high Overall Equipment Effectiveness (OEE) is essential not just for efficiency, but for ensuring product quality, regulatory compliance, and cost control. In this blog, we will explore how a data-driven approach to OEE investigation combines real-time data with scientific analysis to guide impactful line modifications and reduce downtime. Why fill-and-finish […]

Martin Van Trieste is an accomplished entrepreneur, board governance expert, executive coach and biopharmaceutical executive. Martin is the President Emeritus. He was the founder and CEO of Civic Rx, and was previously Amgen’s Chief Quality Officer. He also serves on the boards for Redica Systems. In 2023, SmartSkin was honoured to welcome Martin Van Trieste as Chair of […]

In high-speed manufacturing, efficiency is paramount. Whether you're producing beverages in aluminum, glass, or PET, or aseptic pharmaceutical products, every second of downtime and every defective container translates directly into wasted product, lost revenue, and rising costs. SmartSkin is more than just a quality control tool—it’s a strategic investment in efficiency, waste reduction, and profitability. […]

Imagine a world where every vial, syringe, cartridge and every drug is handled perfectly—without defects, recalls, or safety risks. That world is possible today using digital twins. A Head of Quality in a biopharmaceutical company is responsible for ensuring the highest standards for product integrity and patient safety are maintained. On a daily basis, our work engages this difficult balance: quality, efficiency, and cost-effectiveness. However, frequent line rejects and recalls-many related to glass defects-have come through loud and clear that some form of innovation is urgently called for to enhance the traditional processes and equipment. Having researched and piloted the new technologies, I strongly feel that SmartSkin Technologies offers a transformative solution to product quality, patient safety, and large production cost-cutting. The Following reasons make me believe that SmartSkin Technologies stands out as one of the most valuable additions to the pharmaceutical industry today. For these facts, I joined the Board of Directors with SmartSkin. The Impact of Line Rejects and Recalls In recent years, our industry has grappled with the rising number of product recalls stemming from defects in glass containers. These recalls, frequently due to cracks, chips, or other imperfections, are financially burdensome and, more importantly, risk patient safety. Even when these products don't make it to market, the sheer volume of rejects within our filling lines significantly negatively impacts operational efficiency and yield.

Investing in SmartSkin’s diagnostic and optimization technology is not just about improving efficiency—it’s about unlocking significant cost savings, increased production output, and improved product quality. Whether you’re in beverage, food, or pharmaceutical manufacturing, the right data can transform your bottom line. But how much does SmartSkin really save? Let’s look at real-world numbers from top […]